Summary

Veterinary Pain Management Market Forecast to 2030

Market Overview
Global Veterinary Pain Management market is projected to register a healthy CAGR of 6.44% during the reviewt period. Developing commonness of painful and fiery illnesses in creatures and ascend in sidekick creature proprietorship and huge pet populace are driving market development.
The ascent in sidekick creature possession and enormous animals’ populace, ascend in pet protection with a flood in creature wellbeing consumption, and developing predominance of creature illnesses are supposed to drive the development of the worldwide veterinary pain management market.
The rising number of pet people across the globe is supposed to help market development over the forecast period. For example, as per the American Culture for the Anticipation of Mercilessness to Creatures (ASPCA), around 6.5 million sidekick creatures enter the US creature shields cross country every year. Besides, as expressed by the American Pet Items Affiliation 2015 to 2016 (APPA) study, roughly 44% of all families in the US had a canine, and 35% had a feline.
Market Segmentation
Devices and drugs are included in the product-based segmentation of the worldwide veterinary pain treatment market. The market has been further divided into categories based on pharmaceuticals, including opioids, local anesthetics, nonsteroidal anti-inflammatory drugs (NSAIDs), and others. The NSAIDs category has been further divided into categories such as etodolac, meloxicam, and others.
Joint pain, postoperative pain, cancer, and other conditions are among the applications used to segment the worldwide veterinary pain management market.
Companion and farm animals are the two animal types used to segment the worldwide veterinarian pain management market. Dogs, cats, horses, and other animals have been further subdivided under companion animals. The market has been further subdivided into cattle, pigs, poultry, and other livestock-based animals.
The global veterinary pain management market segmentation is based on a distribution channel that includes veterinary hospitals & clinics, pharmacies, and online pharmacies.
Regional Insights
The North America clear aligners market represented the biggest market share in 2022. This is because of the rising pet populace and the rising number of neurological sicknesses in the region. Besides, the presence of numerous observable players like Zoetis (New Jersey, US), Merck and Co., Inc. (New Jersey, US), and Assisi Creature Wellbeing (New Mexico, US) in this region is the significant driving variable of the market in the North America.
Europe Veterinary Pain Management market represents the second-largest market owing to the rising pervasiveness of contagious creature sicknesses and expanded center around the wellbeing and prosperity of creatures is driving the interest in pain management items.
The Asia-Pacific Veterinary Pain Management market expansion is attributed to the presence of quickly creating economies of China, India, and South Korea. The region gives numerous valuable chances to market players to develop. The expanded pet selections and development in the number of inhabitants in sidekick creatures is supposed to drive the market development.
The Middle East and Africa region has less monetary turns of events and very low pay because of which the region represents the least market share yet is supposed to develop with the to further developing veterinary medical care offices and extension of the working-class populace in these regions.
Major Players
Companies such as Boehringer Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Dechra Pharmaceuticals PLC (Northwich, UK), Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), Assisi Animal Health(New Mexico, US), Eltech K-Laser (Treviso, Italy), Chanelle Pharma (Galway, Ireland), and Elanco (Indiana, US).

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING PREVALENCE OF PAINFUL AND INFLAMMATORY DISEASES IN ANIMALS
4.2.2 RISE IN COMPANION ANIMAL OWNERSHIP & LARGE PET POPULATION
4.2.3 RISE IN PET INSURANCE WITH GROWING ANIMAL HEALTH EXPENDITURE
4.3 RESTRAINTS
4.3.1 LACK OF AWARENESS REGARDING ANIMAL HEALTH
4.3.2 UNAFFORDABILITY OF VETERINARY SERVICES IN UNDERDEVELOPED AND DEVELOPING REGIONS
4.4 OPPORTUNITIES
4.4.1 RISING INITIATIVES BY THE GOVERNMENT AND OTHER ORGANIZATIONS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE VETERINARY PAIN MANAGEMENT MARKET
5.3.1 IMPACT SUPPLY CHAIN DISRUPTIONS
5.3.2 IMPACT ON VETERINARY VISITS AND PROCEDURES
5.3.1 IMPACT ON ADAPTATION TO NEW PRACTICES AND TECHNOLOGIES
6 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 MEDICATION
6.2.1 NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
6.2.1.1.1 MELOXICAM
6.2.1.2 ETODOLAC
6.2.1.3 OTHERS
6.2.2 OPIOIDS
6.2.3 LOCAL ANESTHETICS
6.2.4 OTHERS
6.3 DEVICES
6.3.1 LASER THERAPY DEVICES
6.3.2 TENS UNITS
7 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 JOINT PAIN
7.3 POSTOPERATIVE PAIN
7.4 CANCER
7.5 OTHERS
8 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY ANIMAL TYPE
8.1 OVERVIEW
8.2 COMPANION ANIMALS
8.2.1 DOGS
8.2.2 CATS
8.2.3 HORSES
8.2.4 OTHERS
8.3 LIVESTOCK ANIMALS
8.3.1 CATTLE
8.3.2 PIGS
8.3.3 POULTRY
8.3.4 OTHERS
9 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 VETERINARY HOSPITALS & CLINICS
9.3 PHARMACIES
9.4 ONLINE PHARMACIES
10 GLOBAL VETERINARY PAIN MANAGEMENT MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST
10.5.3 AFRICA
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT APPROVAL AND LAUNCH
11.6.2 EXPANSION
11.6.3 ACQUISITION
11.7 FINANCIAL MATRIX
11.7.1 SALES (USD MILLION), 2022
11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022
12 COMPANY PROFILES
12.1 BOEHRINGER INGELHEIM
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 VETOQUINOL
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 CEVA ANIMAL HEALTH, LLC
12.3.1 COMPANY OVERVIEWS
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 KEY STRATEGIES
12.4 CHANELLE PHARMA
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 ELANCO
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 DECHRA PHARMACEUTICALS PLC
12.6.1 COMPANY OVERVIEWS
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 KEY STRATEGIES
12.7 ZOETIS
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 MERCK & CO., INC
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 ASSISI ANIMAL HEALTH
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 ELTECH K-LASER
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY PRODUCT, 2019–2030 (USD MILLION)

TABLE 4 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR MEDICATION, BY REGION 2019–2030 (USD MILLION)

TABLE 5 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR MEDICATION, BY TYPE 2019–2030 (USD MILLION)

TABLE 6 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION 2019–2030 (USD MILLION)

TABLE 7 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE 2019–2030 (USD MILLION)

TABLE 8 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR MELOXICAM, BY REGION 2019–2030 (USD MILLION)

TABLE 9 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR ETODOLAC, BY REGION 2019–2030 (USD MILLION)

TABLE 10 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019–2030 (USD MILLION)

TABLE 11 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OPIOIDS, BY REGION 2019–2030 (USD MILLION)

TABLE 12 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR LOCAL ANESTHETICS, BY REGION 2019–2030 (USD MILLION)

TABLE 13 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019–2030 (USD MILLION)

TABLE 14 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR DEVICES, BY REGION 2019–2030 (USD MILLION)

TABLE 15 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY APPLICATION, 2019–2030 (USD MILLION)

TABLE 16 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR JOINT PAIN, BY REGION 2019–2030 (USD MILLION)

TABLE 17 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR POSTOPERATIVE PAIN, BY REGION 2019–2030 (USD MILLION)

TABLE 18 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR CANCER, BY REGION 2019–2030 (USD MILLION)

TABLE 19 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019–2030 (USD MILLION)

TABLE 20 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY ANIMAL TYPE, 2019–2030 (USD MILLION)

TABLE 21 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR COMPANION ANIMALS, BY REGION 2019–2030 (USD MILLION)

TABLE 22 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019–2030 (USD MILLION)

TABLE 23 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR DOGS, BY REGION 2019–2030 (USD MILLION)

TABLE 24 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR CATS, BY REGION 2019–2030 (USD MILLION)

TABLE 25 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR HORSES, BY REGION 2019–2030 (USD MILLION)

TABLE 26 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019–2030 (USD MILLION)

TABLE 27 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR LIVESTOCK ANIMALS, BY REGION 2019–2030 (USD MILLION)

TABLE 28 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2030 (USD MILLION)

TABLE 29 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR CATTLE, BY REGION 2019–2030 (USD MILLION)

TABLE 30 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR PIGS, BY REGION 2019–2030 (USD MILLION)

TABLE 31 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR POULTRY, BY REGION 2019–2030 (USD MILLION)

TABLE 32 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR OTHERS, BY REGION 2019–2030 (USD MILLION)

TABLE 33 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2030 (USD MILLION)

TABLE 34 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR VETERINARY HOSPITALS AND CLINICS, BY REGION 2019–2030 (USD MILLION)

TABLE 35 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR PHARMACIES, BY REGION 2019–2030 (USD MILLION)

TABLE 36 GLOBAL VETERINARY PAIN MANAGAMENT MARKET, FOR ONLINE PHARMACIES, BY REGION 2019–2030 (USD MILLION)

TABLE 37 GLOBAL: VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2019-2030 (USD MILLION)

TABLE 38 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)

TABLE 39 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 40 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 41 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 42 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 43 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 44 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 45 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 46 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 47 US: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 48 US: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 49 US: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 50 US: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 51 US: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 52 US: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 53 US: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 54 US: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 55 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 56 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 57 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 58 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 59 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 60 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 61 CANADA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 62 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 63 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)

TABLE 64 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 65 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 66 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 67 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 68 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 69 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 70 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 71 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 72 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 73 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 74 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 75 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 76 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 77 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 78 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 79 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 80 UK: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 81 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 82 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 83 UK: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 84 UK: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 85 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 86 UK: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 87 UK: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 88 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 89 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 90 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 91 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 92 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 93 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 94 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 95 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 96 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 97 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 98 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 99 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 100 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 101 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 102 ITALY: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 103 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 104 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 105 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 106 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 107 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 108 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 109 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 110 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 111 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 112 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 113 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 114 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 115 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 116 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 117 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 118 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 119 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 120 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019–2030 (USD MILLION)

TABLE 121 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 122 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 123 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 124 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 125 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 126 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 127 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 128 ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 129 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 130 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 131 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 132 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 133 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 134 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 135 CHINA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 136 CHINA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 137 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 138 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 139 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 140 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 141 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 142 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 143 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 144 JAPAN: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 145 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 146 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 147 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 148 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 149 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 150 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 151 INDIA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 152 INDIA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 153 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 154 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 155 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 156 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 157 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 158 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 159 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 160 SOUTH KOREA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 161 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 162 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 163 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 164 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 165 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 166 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 167 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 168 AUSTRALIA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 169 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 170 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 171 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 172 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 173 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 174 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 175 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 176 REST OF ASIA-PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 177 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2019-2030 (USD MILLION)

TABLE 178 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 179 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 180 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 181 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 182 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 183 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 184 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 185 REST OF THE WORLD: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 186 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 187 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 188 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 189 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 190 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 191 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 192 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 193 LATIN AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 194 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 195 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 196 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 197 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 198 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 199 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 200 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 201 MIDDLE EAST: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 202 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2019-2030 (USD MILLION)

TABLE 203 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD MILLION)

TABLE 204 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY TYPE, 2019-2030 (USD MILLION)

TABLE 205 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2019-2030 (USD MILLION)

TABLE 206 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2019-2030 (USD MILLION)

TABLE 207 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR COMPANION ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 208 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, FOR LIVESTOCK ANIMALS, BY TYPE, 2019-2030 (USD MILLION)

TABLE 209 AFRICA: VETERINARY PAIN MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION)

TABLE 1 MAJOR PLAYERS IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET

TABLE 2 BENCHMARKING OF MAJOR COMPETITORS

TABLE 3 MOST ACTIVE PLAYER IN THE GLOBAL VETERINARY PAIN MANAGEMENT MARKET

TABLE 4 PRODUCT APPROVAL AND LAUNCH: GLOBAL VETERINARY PAIN MANAGEMENT MARKET

TABLE 5 EXPANSION: GLOBAL VETERINARY PAIN MANAGEMENT MARKET

TABLE 6 ACQUISITION: GLOBAL VETERINARY PAIN MANAGEMENT MARKET

TABLE 7 BOEHRINGER INGELHEIM: PRODUCTS OFFERED

TABLE 8 BOEHRINGER INGELHEIM: KEY DEVELOPMENTS

TABLE 9 VETOQUINOL: PRODUCTS OFFERED

TABLE 10 CEVA ANIMAL HEALTH, LLC: PRODUCTS OFFERED

TABLE 11 CEVA ANIMAL HEALTH, LLC: KEY DEVELOPMENTS

TABLE 12 CHANELLE PHARMA: PRODUCTS OFFERED

TABLE 13 CHANELLE PHARMA: KEY DEVELOPMENTS

TABLE 14 ELANCO: PRODUCTS OFFERED

TABLE 15 ELANCO: KEY DEVELOPMENTS

TABLE 16 DECHRA PHARMACEUTICALS PLC: PRODUCTS OFFERED

TABLE 17 ZOETIS: PRODUCTS OFFERED

TABLE 18 ZOETIS: KEY DEVELOPMENTS

TABLE 19 MERCK & CO., INC: PRODUCTS OFFERED

TABLE 20 ASSISI ANIMAL HEALTH: PRODUCTS OFFERED

TABLE 21 ELTECH K-LASER: PRODUCTS OFFERED